Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) FCF Margin (QoQ) (2009 - 2025)

Analysis

Dr Reddys Laboratories (RDY) FCF Margin (QoQ) (2009 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -153.00
Sep 30, 2024 329.00
Jun 30, 2024 -593.00
Mar 31, 2024 1,179.00
Dec 31, 2023 -1,953.00
Sep 30, 2023 952.00
Jun 30, 2023 -1,150.00
Mar 31, 2023 -819.00
Dec 31, 2022 2,363.00
Sep 30, 2022 -115.00
Jun 30, 2022 -456.00
Mar 31, 2022 -1,631.00
Dec 31, 2021 2,324.00
Sep 30, 2021 1,716.00
Jun 30, 2021 -2,969.00
Mar 31, 2021 1,429.00
Dec 31, 2020 -846.00
Sep 30, 2020 -91.00
Jun 30, 2020 1,504.00
Mar 31, 2020 -1,117.00